再生元制药公司在过敏治疗领域取得重要进展,该公司两项3期临床试验均获得积极结果,这些试验正在评估针对猫过敏和桦树过敏的首创抗体阻断剂的疗效。
再生元制药公司在过敏治疗领域取得重要进展,该公司两项3期临床试验均获得积极结果,这些试验正在评估针对猫过敏和桦树过敏的首创抗体阻断剂的疗效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.